openPR Logo
Press release

Probiotic IBS Supplements Market US$ 48.79 Mn By 2031 - Ease Abdominal Pain & Balance Intestinal Microbiome

06-20-2025 09:27 AM CET | Food & Beverage

Press release from: DataM Intelligence 4 Market Research LLP

Probiotic IBS Supplements Market

Probiotic IBS Supplements Market

Global Probiotic IBS Supplements Market reached US$ 29.12 million in 2023 and is expected to reach US$ 48.79 million by 2031, growing with a CAGR of 7.65% during the forecast period 2024-2031.

The Probiotic IBS Supplements Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data analysis with expert insights. At DataM Intelligence, we simplify complex market dynamics into actionable strategies-empowering businesses to remain competitive, scale confidently, and capitalize on the right opportunities in an ever-evolving landscape.

Unlock exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://datamintelligence.com/download-sample/probiotic-ibs-supplements-market?kb

Probiotic IBS Supplements Market Overview

Probiotic IBS Supplements are specialized formulations containing beneficial bacteria designed to support gut health and alleviate symptoms of Irritable Bowel Syndrome (IBS), such as bloating, abdominal pain, and irregular bowel movements.

Research Methodology:

The global Probiotic IBS Supplements Market research report is based on a combination of primary and secondary data sources. The study carefully analyzes various factors influencing the industry, including government regulations, market dynamics, competitive landscape, historical trends, current conditions, and technological progress. It also evaluates future developments, related industry trends, market volatility, growth prospects, potential obstacles, and emerging challenges.

Segment Covered in the Probiotic IBS Supplements Market:

By Strain: Lactobacillus, Bifidobacterium, Other

By Form: Tablet, Capsules, Liquid, Powder, Others

By Distribution Channel: Supermarkets/Hypermarkets, Pharmacy/Health Stores, Online Stores, Other

By End-User: Infants, Children, Adults, Seniors

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/probiotic-ibs-supplements-market?kb

List of the Key Players in the Probiotic IBS Supplements Market:

The Good Bug, Zeroharm Sciences Private Limited, Menoveda Life Sciences Private Limited, Unique Biotech Limited, Projoy Pvt Ltd, Pure NSM - Nutritional Supplement Manufacturers, Inc., Nature's Bounty, Hyperbiotics, Advanced Vital Enzymes Private Ltd and Wren Laboratories Ltd.

Industry Development:

In August 2023, Hyperbiotics launched PRO-IBS Support, an advanced formulation designed to relieve gut discomfort and dysfunction associated with IBS. This innovative product combines a dual-action synergistic blend of Lactiplantibacillus plantarum 299v and a highly bioavailable Boswellia serrata extract for enhanced therapeutic effectiveness.

Regional Analysis for Probiotic IBS Supplements Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Go-to-market Strategy.

➡ Neutral perspective on the market performance.

➡ Customized regional/country reports as per request and country level analysis.

➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➠ What are the global sales, production, consumption, imports, and exports in the Probiotic IBS Supplements market?

➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?

➠ What key opportunities and challenges do vendors face in the Probiotic IBS Supplements industry?

➠ Which product types, applications, or end-users are driving market growth, and what is their market share?

➠ What are the major growth drivers and restraints of the Probiotic IBS Supplements market?

Buy Now & Unlock 360° Market Intelligence:
Purchase Your Subscription to Power Your Strategy with Precision: https://www.datamintelligence.com/reports-subscription?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Probiotic IBS Supplements Market US$ 48.79 Mn By 2031 - Ease Abdominal Pain & Balance Intestinal Microbiome here

News-ID: 4075295 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Computational Biology Market | Powering Genomics, Drug Discovery & Disease Modeling | Most Leading - Simulations Plus Inc., Insilico Biotechnology AG, Compugen Ltd., Certara., Nimbus Therapeutics
Computational Biology Market | Powering Genomics, Drug Discovery & Disease Model …
Global Computational Biology market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031. The Computational Biology Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their innovative
Hemoglobin A1c Testing Devices Market Worth $3.2 Billion by 2033 | Growth Report 2025-2033
Hemoglobin A1c Testing Devices Market Worth $3.2 Billion by 2033 | Growth Report …
The Global Hemoglobin A1c Testing Devices Market reached US$ 1.5 billion in 2024 and is expected to reach US$ 3.2 billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033. The Hemoglobin A1c Testing Devices Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data analysis
Transcranial Magnetic Stimulator Market: Non-Invasive Brain Therapy for Depression and Mental Health
Transcranial Magnetic Stimulator Market: Non-Invasive Brain Therapy for Depressi …
The Transcranial Magnetic Stimulator Market size was valued at US$ 1,125.25 million in 2022 and is estimated to reach US$ 2,244.79 million by 2030, growing at a CAGR of 9.2% during the forecast period (2024-2031). The Transcranial Magnetic Stimulator Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data analysis
Antidepressant Drugs Market | Rising Demand Driven by Global Mental Health Awareness | Most Companies - Eli Lilly and Company, GlaxoSmithKline Plc., LGM Pharma LLC, Apotex Inc., Zhejiang Huahai Pharmaceutical Co. Ltd
Antidepressant Drugs Market | Rising Demand Driven by Global Mental Health Aware …
Global Antidepressant Drugs Market reached US$ 14.3 billion in 2022 and is expected to reach US$ 20.6 billion by 2031 growing with a CAGR of 5.56% during the forecast period 2024-2031. The Antidepressant Drugs Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their innovative

All 5 Releases


More Releases for IBS

Integrated Bridge Systems Market Report 2018: Segmentation by Platform (Commerci …
Global Integrated Bridge Systems market research report provides company profile for Northrop Grumman Sperry Marine (U.K.), Raytheon Anschütz (Germany), Rolls Royce (U.K.), L-3 Communications Mapps Inc. (Canada), FURUNO Electric Shokai Ltd. (Japan) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR
IBS' solution to power China’s first Cruise Line
Trivandrum, 16 January 2013: Henna, the largest cruise ship in mainland China will run on IBS’ inventory and pricing management solution, Cruise Partner, when it makes its maiden journey on January 26, 2013. China based HNA Tourism Cruise and Yacht Management Company unveiled this cruise ship on November 28, 2012. Henna has 739 rooms for 1,965 passengers, as well as a complete range of facilities for living and entertainment. HNA
Vikash Sureka joins IBS as Chief Financial Officer
Trivandrum (India), 17 May 2012: IBS Software Services, the leading provider of new-generation IT solutions to the global aviation industry, has appointed Mr Vikash Sureka as its Chief Financial Officer. He will head the Finance, Legal, Company Affairs and Administration functions of IBS operations world-wide. A Chartered Accountant, Vikash has over 19 years of experience mostly in senior executive roles managing business globally with proven proficiency in Investor Relations, P&L
HaCon and IBS combine expertise in railway operation
Hanover (2010-07-06). Two Hanoverian companies now combine their expertise in questions of railway operations: With effect from 1 July 2010, the HaCon Ingenieurgesellschaft mbH, took over the engineering firm for railway operating systems (Ingenieurbüro für Bahnbetriebssysteme GmbH – IBS). This way HaCon expanded its services to include the areas operation simulation, vehicle and personnel planning and construction operations planning. This also includes consulting services concerning railway systems issues, such as travel
Raytheon Anschütz IBS for new Intership Bulkers
Raytheon Anschütz was recently awarded a contract to supply their Integrated Bridge System (IBS) to two new bulk carriers. The bulkers will be built at New Times Shipyard in Jingjiang, China. The delivery to the Cyprus based shipping company Intership Navigation Co. Ltd., a member of the German Hartmann Group, is scheduled for August and October 2011. The new bulkers, each with a capacity of 176,000 dwt, will be equipped
CoCoNet enhances MULTIVERSA IBS by OFTP access protocol
CoCoNet enhances the modern e-banking-platform MULTIVERSA IBS International Banking Server through an OFTP access channel (Odette File Transfer Protocol) for the data transmission between international banks and corporate customers. MULTIVERSA IBS is a modular and scalable platform for receiving and processing payment transaction data and delivering customer specific account information like account statements, intraday reports, returns and foreign exchange rate information. The initial situation at banks that now also offer